CLINICAL_TRIALS
trial_result
· 2013-03-15
Clinical Trial Update: An Eight-week Study of SSR411298 as Treatment for Major Depressive Disorder in Elderly Patients [Phase 2]
Summary
A Phase 2 eight-week trial of SSR411298 for major depressive disorder in elderly patients has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED